Published: October 2011
No. of Pages: 80
Price: $ 3500
GBI Research, the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017” which provides insights into global contraceptives market and market forecast until 2017. Report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the contraceptives used. The report provides an in-depth analysis of the oral contraceptives, topical contraceptive, injectable contraceptive, intrauterine devices, condoms and vaginal rings. The report examines the oral, topical and injectable contraceptives treatment usage patterns. The report also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape including major players in contraceptives market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in contraceptives market.
Browse All: Pharmaceuticals Market
Scope
• The report analyzes market characterization, pipeline analysis and key M&A trends in the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.
• The scope of this report includes:
• Data and analysis on the contraceptives market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
• Annualized market data for the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002 to 2010, with forecasts to 2017.
• Market data on the therapeutic landscape which covers oral, topical, injectable contraceptive and includes market revenues, treatment usage patterns and annual cost of therapy.
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the contraceptives market which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.
• Key M&A activities and Licensing Agreements that took place from 2005 to 2011 in the contraceptives market.
Reasons to Buy
• The report will enhance your decision making capability. It will allow you to
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
• Device a more tailored country strategy through the understanding of key drivers and barriers of the contraceptives market.
• Develop key strategic initiatives by understanding the key focus areas of leading companies.
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
No comments:
Post a Comment